Additional file 4: of α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas
Year: 2019
Type: dataset
Abstract: Table S2. List of all nonsynonymous coding mutations in six tumor cell lines. (XLSX 84 kb)
Source: Figshare
Authors: E. Dodagatta-Marri, D. Meyer, M. Reeves, R. Paniagua, M. To, M. Binnewies, M. Broz, H. Mori, D. Wu, M. Adoumie, R. Rosario, O. Li, T. Buchmann, B. Liang, J. Malato, F. Arce Vargus, D. Sheppard, B. Hann, A. Mirza, S. Quezada, M. Rosenblum, M. Krummel, A. Balmain, R. Akhurst
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4394384899